Vaxcyte, Inc.
PCVX- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001649094
In the last 90 days, Vaxcyte, Inc. insiders filed 0 open-market purchases and 8 sales; 331 institutions reported holding it in 13F filings for Q2 2026, worth $9.71B in total; Maverick Capital is the only superinvestor holding it.
13F holders, Q1 2023
Institutional positions in Vaxcyte, Inc. as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 188
- −8 vs. Q4 2022
- Shares held
- 84.1M
- +4.56M (+5.7%) vs. Q4 2022
- Total value
- $3.15B
- −$661.1M (−17.3%) vs. Q4 2022
- New holders
- 23
- 70 more added
- Sold out
- 31
- 63 more reduced
2 institutions that held it in Q4 2022 haven't filed for Q1 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting PCVX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 331 | $9.71B |
| Q1 2026 | 336 | $9.44B |
| Q4 2025 | 295 | $6.81B |
| Q3 2025 | 285 | $5.09B |
| Q2 2025 | 294 | $4.80B |
| Q1 2025 | 315 | $5.88B |
| Q4 2024 | 323 | $11.5B |
| Q3 2024 | 329 | $15.6B |
| Q2 2024 | 265 | $9.26B |
| Q1 2024 | 251 | $8.13B |
| Q4 2023 | 223 | $6.47B |
| Q3 2023 | 202 | $5.17B |
| Q2 2023 | 197 | $5.00B |
| Q1 2023 | 188 | $3.15B |
| Q4 2022 | 198 | $3.91B |
| Q3 2022 | 126 | $1.36B |
| Q2 2022 | 106 | $1.12B |
| Q1 2022 | 88 | $1.20B |
| Q4 2021 | 87 | $1.06B |
| Q3 2021 | 78 | $1.10B |
| Q2 2021 | 75 | $972.7M |
| Q1 2021 | 74 | $869.2M |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding Vaxcyte, Inc.; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| American Century Companies Inc | 0 | $0 | 0.00% | −8,062−100.0% | Sold out |
| Lazard Asset Management LLC | 0 | $0 | 0.00% | −7,741−100.0% | Sold out |
| CenterBook Partners LP | 0 | $0 | 0.00% | −5,709−100.0% | Sold out |
| Gyon Technologies Capital Management, LP | 0 | $0 | 0.00% | −5,669−100.0% | Sold out |
| MML Investors Services, LLC | 0 | $0 | 0.00% | −5,211−100.0% | Sold out |
| Financial Advocates Investment Management | 0 | $0 | 0.00% | −4,564−100.0% | Sold out |
| Mackenzie Financial Corp | 0 | $0 | 0.00% | −4,479−100.0% | Sold out |
| Kula Investments, LLC | 0 | $0 | 0.00% | −4,410−100.0% | Sold out |
| Advisory Research Inc | 0 | $0 | 0.00% | −4,304−100.0% | Sold out |
| Creative Planning | 0 | $0 | 0.00% | −4,269−100.0% | Sold out |
| Lee Financial Co | 0 | $0 | 0.00% | −487−100.0% | Sold out |
| Comerica Securities,inc. | 0 | $0 | 0.00% | −336−100.0% | Sold out |
| Advisory Services Network, LLC | 0 | $0 | 0.00% | −232−100.0% | Sold out |
| Allworth Financial LP | 0 | $0 | 0.00% | −31−100.0% | Sold out |
| McElhenny Sheffield Capital Management, LLC | 0 | $0 | 0.00% | −29−100.0% | Sold out |
| Quadrant Capital Group LLC | 0 | $0 | 0.00% | −27−100.0% | Sold out |
| Parallax Volatility Advisers, L.P. | 0 | $0 | 0.00% | −24−100.0% | Sold out |
| Focused Wealth Management, Inc | 0 | $0 | 0.00% | −9−100.0% | Sold out |
| Rockefeller Capital Management L.P. | 0 | $0 | 0.00% | −19−100.0% | Sold out |
| Abingworth LLP | – | – | – | – | Not filed |
| Alpha Paradigm Partners, LLC | – | – | – | – | Not filed |